Our results showed that first, compared with positive control TNF-α, IκB-α phosphorylation could not be detected in HCC cells after treatment with Lexa, suggesting that specific binding to DR5 avoids activation of the NF-κB signaling pathway in HCC cells. Here, NFKBIA is linked to hepatocellular carcinoma.